Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study

Saved in:
Bibliographic Details
Published inLeukemia & lymphoma Vol. 60; no. 6; pp. 1563 - 1567
Main Authors Chaoui, Driss, Hacini, Maya, Fitoussi, Olivier, Karlin, Lionel, Arkam, Yazid, Jourdan, Eric, Orfeuvre, Hubert, Voillat, Laurent, Sanhes, Laurence, Leprêtre, Stéphane, Liu, Kun Lun, Barry, Marly, Tempescul, Adrian, Dilhuydy, Marie-Sarah, Chaib, Abdelaziz, Slama, Borhane, Labourey, Jean Luc, Benbrahim, Omar, Dreyfus, Brigitte, Mahé, Béatrice, Maynadié, Marc, Delmer, Alain, Benkanoun, Chahinez, Boissard, Frédéric, Gandon, Sophie, Veerabudun, Kalaivani, Choquet, Sylvain
Format Journal Article Publication
LanguageEnglish
Published United States Taylor & Francis 12.05.2019
Subjects
Hematology
Human health and pathology
Life Sciences
Chronic lymphocytic leukemia
PERLE study
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:1042-8194
1029-2403
DOI:10.1080/10428194.2018.1533130